|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors of the Stomach: Report of Three Cases
Ji Seon Oh, Jae-Lyun Lee, Mi-Jung Kim, Min-Hee Ryu, Heung Moon Chang, Tae Won Kim, Se Jin Jang, Jeong Hwan Yook, Sung Tae Oh, Byung Sik Kim, Yoon-Koo Kang
Cancer Res Treat.
2006;38(3):178-183. Published online June 30, 2006 DOI:
https://doi.org/10.4143/crt.2006.38.3.178
Crossref 7
Optimal Timing for the Administration of Capecitabine with Preoperative Chemoradiation for Locally Advanced Rectal Cancer
Young Ju Noh, Won Sik Choi, Jong Hoon Kim, Jin Cheon Kim, Chang Sik Yu, Hee Cheol Kim, Tae Won Kim, Heung Moon Chang, Min Hee Ryu, Seung Do Ahn, Sang-wook Lee, Seong Soo Shin, Jung Eun Lee, Eun Kyung Choi
Cancer Res Treat.
2006;38(1):30-34. Published online February 28, 2006 DOI:
https://doi.org/10.4143/crt.2006.38.1.30
Crossref 1
Efficacy and Safety Study of Docetaxel as Salvage Chemotherapy in Metastatic Gastric Cancer Failing Fluoropyrimidine and Platinum Combination Chemotherapy
Jae-Lyun Lee, Min-Hee Ryu, Heung Moon Chang, Tae-Won Kim, Jeong Hwan Yook, Sung Tae Oh, Byung Sik Kim, Jung Shin Lee, Yoon-Koo Kang
Cancer Res Treat.
2005;37(4):201-207. Published online August 31, 2005 DOI:
https://doi.org/10.4143/crt.2005.37.4.201
Crossref 4
Responsiveness of CPT-11 in Respect to hMLH1 and hMSH2 Protein Expression in the Primary Colorectal Cancer
In Ja Park, Hee Cheol Kim, Chang Sik Yu, Heung Moon Chang, Jea Hwan Lee, Jong Hoon Kim, Tae Won Kim, Jung Sun Kim, Jin Cheon Kim
Cancer Res Treat.
2004;36(6):360-366. Published online December 31, 2004 DOI:
https://doi.org/10.4143/crt.2004.36.6.360
Prospective Phase II Study of Preoperative Chemoradiation with Capecitabine in Locally Advanced Rectal Cancer
Jin-hong Park, Jong Hoon Kim, Seung Do Ahn, Sang-wook Lee, Seong Soo Shin, Jin Cheon Kim, Chang Sik Yu, Hee Cheol Kim, Yoon-Koo Kang, Tae Won Kim, Heung Moon Chang, Min Hee Ryu, Eun Kyung Choi
Cancer Res Treat.
2004;36(6):354-359. Published online December 31, 2004 DOI:
https://doi.org/10.4143/crt.2004.36.6.354
Crossref 7
Combination Chemotherapy of Oxaliplatin, 5-Fluorouracil, and Leucovorin in 5-Fluorouracil-Pretreated Patients with Metastatic Colorectal Cancer
Soo Mee Bang, Eun Kyung Cho, Jae Hwan Oh, Heung Moon Chang, Jin Seok Ahn, Jung Ae Lee, Young Iee Park, Myung Jue Ahn, Young Suk Park, Dong Bok Shin, Jae Hoon Lee
Cancer Res Treat.
2001;33(5):414-419. Published online October 31, 2001 DOI:
https://doi.org/10.4143/crt.2001.33.5.414
Crossref 1
Neoadjuvant Chemotherapy with High-dose Methotrexate , Adriamycin and Cisplatin for Non - Metastatic Osteosarcoma
Keun Seok Lee, Heung Moon Chang, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim, Sang Hoon Lee, Eui Keun Ham, Han Ku Lee
J Korean Cancer Assoc.
1996;28(6):1092-1104.
The Postoperative Adjuvant Chemotherapy of Gastric Cancer with 5 - Fluorouracil , Adriamycin and Mitomycin - C ( FAM )
Young Suk Park, Heung Moon Chang, Keun Chil Park, Dae Seog Heo, Yung Jue Bang, Jae Gahb Park, Kuhn Uk Lee, Kuk Jin Choe, Soo Tae Kim, Noe Kyeong Kim
J Korean Cancer Assoc.
1994;26(6):853-860.
A Case of Multiple Myeloma with Non - Hodgkin's Lymphoma
Heung Moon Chang, Won Seok Kim, In Shon, Chul Woo Kim, Dae Seog Heo, Yung Jue Bang, Seon Yang Park, Byoung Kook Kim, Noe Kyeong Kim
J Korean Cancer Assoc.
1994;26(5):847-853.
Second - line , Chemotherapy with 5 - Fluorouracil Etoposide , Doxorubicin , Cisplatin , Cyclophosphamide , Adriamycin , Vincristine , Predais
Heung Moon Chang, Hyun Ah Kim, Won Seok Kim, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim
J Korean Cancer Assoc.
1994;26(1):82-89.
1
Journal Impact Factor 4.6